Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
• Share prices of Scotts Miracle-Gro Company (NYSE:SMG) dipped 6.02% after the company reduced its earnings estimate for the fiscal year 2011
• Shares of Owens-Illinois (NYSE:OI) dropped 13.54% to close at $25.54 after the company said its second quarter earnings figures could fall due to a jump in manufacturing and delivery expenses
• Johnson & Johnson (NYSE:JNJ) is reportedly pulling out of the drug-coated heart stent market because of continually declining sales. The global market for this segment is valued at $4 billion
• Analysts at Jefferies & Co. initiated coverage on shares of General Mills, Inc. (NYSE:GIS) with "Hold" rating and a target price of $40
• Analysts at Jefferies & Co. initiated coverage on Shares of Kellogg (NYSE:K) with "Underperform" rating and also lowered the target price of the stock to $47
• Analysts at Auriga downgraded Myriad Genetics (NASDAQ:MYGN) to "Hold" rating from "Buy" rating, cutting the target price to $25 from $27
• Analysts at Wedbush downgraded shares of Ceradyne (NASDAQ:CRDN) to "Neutral" rating from "Outperform" rating
• Analysts at Wedbush downgraded shares of AngioDynamics (NASDAQ:ANGO) to an "Underperform" rating
• Wells Fargo upgraded Hospitality Properties Trust (NYSE:HPT) to "Outperform" rating from "Market Perform" rating
• Pharma company AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) has priced its public offering of 5.75 million shares at $17.50 per share. This offering is expected to bring in $100.6 million before expenses, which will be used for general corporate needs
Read the full Snapshot Report on SMG
Read the full Analyst Report on OI
Read the full Analyst Report on JNJ
Read the full Analyst Report on GIS
Read the full Analyst Report on K
Read the full Analyst Report on MYGN
Read the full Analyst Report on ANGO
Read the full Snapshot Report on HPT
Read the full Snapshot Report on AVEO